- Home
- LNSR vs OPRX Comparison
LNSR vs OPRX Comparison
Compare LNSR & OPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LNSR | OPRX |
|---|---|---|
| Founded | 2004 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Electronics | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 146.7M | 120.1M |
| IPO Year | 2005 | 2008 |
Fundamental Metrics
Financial Performance| Metric | LNSR | OPRX |
|---|---|---|
| Price | $5.60 | $5.11 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 6 |
| Target Price | $10.00 | ★ $16.67 |
| AVG Volume (30 Days) | 48.2K | ★ 509.9K |
| Earning Date | 05-11-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 124.55 |
| EPS | ★ N/A | N/A |
| Revenue | $58,435,000.00 | ★ $109,429,000.00 |
| Revenue This Year | $10.06 | $3.88 |
| Revenue Next Year | $41.48 | $8.34 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | 9.24 | ★ 18.78 |
| 52 Week Low | $5.06 | $4.57 |
| 52 Week High | $13.47 | $22.25 |
Technical Indicators
Market Signals| Indicator | LNSR | OPRX |
|---|---|---|
| Relative Strength Index (RSI) | 41.81 | 42.75 |
| Support Level | $5.34 | $4.57 |
| Resistance Level | $6.20 | $7.10 |
| Average True Range (ATR) | 0.22 | 0.33 |
| MACD | -0.00 | 0.06 |
| Stochastic Oscillator | 5.65 | 44.69 |
Price Performance
Historical ComparisonAbout LNSR LENSAR Inc.
LENSAR Inc is a commercial-stage medical device company focused on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, simplified procedure planning, efficient design, and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. Geographically, the company generates the majority of its revenue from the United States, followed by Europe and Asia.
About OPRX OptimizeRx Corporation
OptimizeRx Corp is engaged in the healthcare market in the United States. is a digital healthcare technology company that connects over two million HCPs and millions of their patients through an intelligent technology platform embedded within a proprietary omnichannel network. OptimizeRx helps life sciences organizations engage and support their customers through its combined HCP and DTC marketing strategies.